Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biomerica (BMRA) Interest & Investment Income (2016 - 2023)

Historic Interest & Investment Income for Biomerica (BMRA) over the last 14 years, with Q2 2023 value amounting to $55632.0.

  • Biomerica's Interest & Investment Income rose 66628.1% to $55632.0 in Q2 2023 from the same period last year, while for May 2023 it was $133000.0, marking a year-over-year increase of 39259.26%. This contributed to the annual value of $133000.0 for FY2023, which is 39259.26% up from last year.
  • As of Q2 2023, Biomerica's Interest & Investment Income stood at $55632.0, which was up 66628.1% from $36086.0 recorded in Q1 2023.
  • Biomerica's Interest & Investment Income's 5-year high stood at $55632.0 during Q2 2023, with a 5-year trough of $28.0 in Q3 2022.
  • Its 5-year average for Interest & Investment Income is $18349.1, with a median of $8037.0 in 2020.
  • As far as peak fluctuations go, Biomerica's Interest & Investment Income soared by 792873.24% in 2019, and later plummeted by 9958.85% in 2022.
  • Over the past 5 years, Biomerica's Interest & Investment Income (Quarter) stood at $4488.0 in 2019, then surged by 77.87% to $7983.0 in 2020, then fell by 13.37% to $6916.0 in 2021, then skyrocketed by 496.5% to $41254.0 in 2022, then surged by 34.85% to $55632.0 in 2023.
  • Its Interest & Investment Income stands at $55632.0 for Q2 2023, versus $36086.0 for Q1 2023 and $41254.0 for Q4 2022.